01 March 2004
Reliability of the rapid bedside whole-blood quantitative cardiac troponin T assay in the diagnosis of myocardial injury in patients with acute coronary syndrome
Salam Saadeddin, Mohammed Habbab, Hisham Siddieg, Mahmoud Fayomi, Rofaida DafterdarMed Sci Monit 2004; 10(3): MT43-46 :: ID: 11602
Abstract
Background: A rapid bedside whole-blood quantitative cTnT assay has recently been developed. We evaluated
the reliability of this test for the diagnosis of myocardial injury in patients with acute coronary syndrome (ACS).
Material/Methods: Whole-blood cTnT levels were measured in 96 patients with ACS using the Roche Cardiac Reader[sup]®[/sup] rapid bedside assay device, and the results were compared with serum cTnT levels in the same patients measured by the Roche Elecsys[sup]®[/sup] Immunoanalyzer. There were 50 patients with clinical evidence of myocardial injury and 56 without.
Results: From the qualitative point of view (reporting negative or positive tests), the results of the rapid bedside tests were identical to those obtained by the serum immunoanalyzer. From
quantitative the point of view, the rapid bedside tests could not measure exact values below
0.1 ng/ml (reported negative) or above 2.0 ng/ml (reported >2.0). The measurements made by the rapid bedside tests within the range of 0.1 to 2.0 ng/ml correlated well with those of the serum immunoanalyzer (Cardiac Reader[sup]®[/sup] cTnT=0.61, Elecsys[sup]®[/sup] cTnT+0.12; r=0.88), but their mean values were significantly lower (1.20±0.71 vs. 1.41±1.03, p=0.0007).
Conclusions: The rapid bedside cTnT assay correlates well with immunoanalyzer measurements between
the values of 0.1 and 2.0 ng/ml. However, they tend to give significantly lower values and fail
to give exact values below 0.1 and above 2.0 ng/ml, which may affect their performance in monitoring and managing patients with ACS, and limit their use in predicting outcome.
Keywords: Coronary Arteriosclerosis - diagnosis, Dose-Response Relationship, Drug, Heart Diseases - diagnosis, Heart Injuries - diagnosis, Immunoassay - instrumentation, Immunoassay - methods, Myocardium - metabolism, Reagent Kits, Diagnostic, Reproducibility of Results, Sensitivity and Specificity, Troponin I - blood, Troponin T - blood, Coronary Artery Disease - diagnosis, Dose-Response Relationship, Drug, Heart Diseases - diagnosis, Heart Injuries - diagnosis, Immunoassay - methods, Myocardium - metabolism, Reagent Kits, Diagnostic, Reproducibility of Results, Sensitivity and Specificity, Troponin I - blood, Troponin T - blood
Editorial
01 February 2025 : Editorial
Editorial: Current Approaches to Screening for Lung Cancer in Smokers and Non-SmokersDOI: 10.12659/MSM.948255
Med Sci Monit 2025; 31:e948255
In Press
Review article
Hydrogels in Oral Disease Management: A Review of Innovations in Drug Delivery and Tissue RegenerationMed Sci Monit In Press; DOI: 10.12659/MSM.946122
Clinical Research
Procedure Dynamics in Transfemoral vs Transradial Cerebral Angiography: A Retrospective StudyMed Sci Monit In Press; DOI: 10.12659/MSM.947603
Clinical Research
Predicting Cerebral Small Vessel Disease Burden Based on Thromboelastography in Patients with Acute Ischemi...Med Sci Monit In Press; DOI: 10.12659/MSM.946303
Clinical Research
Long-Term Outcomes of Implanon in Managing Adenomyosis: A 3-Year Prospective StudyMed Sci Monit In Press; DOI: 10.12659/MSM.945972
Most Viewed Current Articles
17 Jan 2024 : Review article 6,969,459
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 701,879
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 25,628
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 20,173
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912